PPN News Staff
FDA Expands Indication for Revlimid for Certain MM Patients
Celgene's Revlimid has a new indication: for MM patients following autologous hematopoietic stem cell ...
FEBRUARY 23, 2017
FDA Wants Boxed Warnings About HBV Reactivation
The FDA is calling on the manufacturers of direct-acting antiviral (DAA) agents to add boxed warnings on their ...
JANUARY 23, 2017
President Signs 21st Century Cures Act
The 21st Century Cures Act is a bill that could accelerate the drug approval process and increase funding for ...
DECEMBER 14, 2016
Senate Passes 21st Century Cures Act
The 21st Century Cures Act, a bill that could accelerate the drug approval process and increase funding for mental ...
DECEMBER 8, 2016
FDA Removes Boxed Warning Regarding Drug–Drug Interactions for Veltassa
The FDA removed the boxed warning regarding the use of other drugs with the oral potassium binder, Veltassa. ...
NOVEMBER 29, 2016
FDA Approves Idelvion for Hemophilia B
In clinical trials, Idelvion maintained factor IX activity levels above 5% over 14 days, resulting in a median ...
MARCH 8, 2016
